Search research articles
Contact Us
Filters
Showing results (681-690 of 686) with videos related to
Page
of 69
Sort By:
You have reached the last page of results.
This site can display upto 686 results.
The Journal of Clinical Investigation
|
March 22, 2016
Motif mimetic of epsin perturbs tumor growth and metastasis
Yunzhou Dong, Hao Wu, H N Ashiqur Rahman, et al.
The Journal of Clinical Investigation
|
November 17, 2015
Motif mimetic of epsin perturbs tumor growth and metastasis
Yunzhou Dong, Hao Wu, H N Ashiqur Rahman, et al.
Science Bulletin
|
January 19, 2023
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)
Linong Ji, Weihong Song, Hui Fang, et al.
Cancer Cell
|
June 18, 2026
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
Jun Liao, Wenxiu Yao, Yan Yu, et al.
Nature Biotechnology
|
October 2, 2018
On-demand manufacturing of clinical-quality biopharmaceuticals
Laura E Crowell, Amos E Lu, Kerry R Love, et al.
Signal Transduction and Targeted Therapy
|
February 18, 2025
Population-level analyses identify host and environmental variables influencing the vaginal microbiome
Lang Qin, Tianyong Sun, Xiao Li, et al.
Page
of 69
Search research articles
Search
Showing results (681-690 of 686) with videos related to
Sort By:
Page
of 69
You have reached the last page of results.
This site can display upto 686 results.
The Journal of Clinical Investigation
|
March 22, 2016
Motif mimetic of epsin perturbs tumor growth and metastasis
Yunzhou Dong, Hao Wu, H N Ashiqur Rahman, et al.
The Journal of Clinical Investigation
|
November 17, 2015
Motif mimetic of epsin perturbs tumor growth and metastasis
Yunzhou Dong, Hao Wu, H N Ashiqur Rahman, et al.
Science Bulletin
|
January 19, 2023
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)
Linong Ji, Weihong Song, Hui Fang, et al.
Cancer Cell
|
June 18, 2026
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
Jun Liao, Wenxiu Yao, Yan Yu, et al.
Nature Biotechnology
|
October 2, 2018
On-demand manufacturing of clinical-quality biopharmaceuticals
Laura E Crowell, Amos E Lu, Kerry R Love, et al.
Signal Transduction and Targeted Therapy
|
February 18, 2025
Population-level analyses identify host and environmental variables influencing the vaginal microbiome
Lang Qin, Tianyong Sun, Xiao Li, et al.
Page
of 69